These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31627509)

  • 21. [Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and results for treatment of prolactin and growth hormone secreting pituitary tumors].
    Wiesner TD; Trantakis C; Meixensberger J; Koch CA; Zimmer C; Paschke R
    Med Klin (Munich); 2005 Apr; 100(4):173-9. PubMed ID: 15834525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
    Felix IA; Horvath E; Kovacs K; Smyth HS; Killinger DW; Vale J
    Acta Neuropathol; 1986; 71(1-2):76-82. PubMed ID: 3776476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of the neural cell adhesion molecule NCAM 140 in human pituitary tumors.
    Aletsee-Ufrecht MC; Langley K; Gratzl O; Gratzl M
    FEBS Lett; 1990 Oct; 272(1-2):45-9. PubMed ID: 2121537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Ki-67 expression is associated with prolactin secreting pituitary adenomas.
    Bălinişteanu B; Cîmpean AM; Ceauşu AR; Corlan AS; Melnic E; Raica M
    Bosn J Basic Med Sci; 2017 May; 17(2):104-108. PubMed ID: 28432860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic 'big' hyperprolactinemia in two men with pituitary adenomas.
    Tritos NA; Guay AT; Malarkey WB
    Eur J Endocrinol; 1998 Jan; 138(1):82-5. PubMed ID: 9461321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Necroses of prolactin-secreting pituitary adenomas under treatment with dopamine agonists: light microscopical and morphometric studies.
    Hallenga B; Saeger W; Lüdecke DK
    Exp Clin Endocrinol; 1988 Sep; 92(1):59-68. PubMed ID: 2906615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary tumors. Current concepts in diagnosis and management.
    Aron DC; Tyrrell JB; Wilson CB
    West J Med; 1995 Apr; 162(4):340-52. PubMed ID: 7747500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric pituitary adenomas.
    Mindermann T; Wilson CB
    Neurosurgery; 1995 Feb; 36(2):259-68; discussion 269. PubMed ID: 7731505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Light and electron microscopical morphometry of pituitary adenomas in hyperprolactinemia.
    Saeger W; Mohr K; Caselitz J; Lüdecke DK
    Pathol Res Pract; 1986 Oct; 181(5):544-50. PubMed ID: 3024139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemistry of prolactin-producing human pituitary adenomas.
    Duello TM; Halmi NS
    Am J Anat; 1980 Aug; 158(4):463-9. PubMed ID: 7006374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemistry of pituitary tumors.
    Heitz PU; Landolt AM; Zenklusen HR; Kasper M; Reubi JC; Oberholzer M; Roth J
    J Histochem Cytochem; 1987 Sep; 35(9):1005-11. PubMed ID: 2440942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical examination of the paraadenomatous "normal" pituitary. An evaluation of prolactin cell hyperplasia.
    Landolt AM; Minder H
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(2):181-93. PubMed ID: 6426162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and epidemiological characteristics of pituitary tumours in a single centre in Saudi Arabia.
    Hussein SH; Wahedi TS; Johani NA; Hakami YA; Alzahrani K; AlMalki MH
    Hormones (Athens); 2018 Jun; 17(2):261-267. PubMed ID: 29858852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Hyperprolactinemia and Granulomatous Mastitis.
    Nikolaev A; Blake CN; Carlson DL
    Breast J; 2016; 22(2):224-31. PubMed ID: 26705962
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.